糖尿病デバイス市場規模、シェア、成長分析：タイプ別、流通チャネル別、最終用途別、地域別 - 産業予測 2025～2032年

糖尿病デバイスの世界市場規模は、2023年に333億米ドルと評価され、予測期間（2025-2032年）のCAGRは8.8％で成長し、2024年の362億3,000万米ドルから2032年には711億4,000万米ドルに成長する見通しです。

世界の疾病負担は、主に座りがちなライフスタイルの増加や都市化によってエスカレートしています。国際糖尿病連合が報告しているように、20～79歳の約5億3,000万人が糖尿病と診断されており、この疾患は脳卒中、心血管疾患、神経損傷など様々な合併症と関連しています。この憂慮すべき動向は、疾病管理に対する意識が高まるにつれて、糖尿病管理機器に対する需要に拍車をかけています。この消費者ニーズの高まりに対応するため、革新的なデザインのインスリンポンプ、ペン、その他の先進的な糖尿病治療技術が登場してきています。その結果、大手メーカーは大きな市場シェアを獲得するために技術革新に注力し、最先端の製品を開発しており、糖尿病ケアソリューションの強化が急務であることを強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

糖尿病デバイス市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• BGMデバイス
  • 自己監視デバイス
  • 血糖値測定器
  • 検査ストリップ
  • ランセット
  • 持続血糖測定装置
  • センサー
  • 送信機
  • 受信機
  • インスリン投与装置
  • ポンプ
  • ペン
  • 注射器
  • ジェットインジェクター

糖尿病デバイス市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• 小売薬局
• 糖尿病クリニック/センター
• オンライン薬局
• その他

糖尿病デバイス市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 診断センター
• ホームケア

糖尿病デバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（Ireland）
• Abbott Laboratories（United States）
• DexCom（United States）
• Novo Nordisk（Denmark）
• Becton, Dickinson and Company（United States）
• Roche（Switzerland）
• Insulet（United States）
• Tandem Diabetes Care（United States）
• Ypsomed（Switzerland）
• Sanofi（France）
• Eli Lilly and Company（United States）
• LifeScan（United States）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Bayer AG（Germany）
• Johnson & Johnson（United States）
• Terumo Corporation（Japan）
• AgaMatrix Holdings（United States）
• ARKRAY USA（United States）
• Nipro Corporation（Japan）

結論と提言

Global Diabetes Device Market size was valued at USD 33.3 billion in 2023 and is poised to grow from USD 36.23 billion in 2024 to USD 71.14 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global illness burden is escalating, primarily driven by increased sedentary lifestyles and urbanization. As reported by the International Diabetes Federation, approximately 530 million individuals aged 20 to 79 are diagnosed with diabetes, a condition linked to various complications such as strokes, cardiovascular issues, and nerve damage. This alarming trend is fueling the demand for diabetes management devices, as awareness of disease control intensifies. Innovatively designed insulin pumps, pens, and other advanced diabetic technologies are emerging to meet this growing consumer need. Consequently, leading manufacturers are focusing on technological innovations and developing cutting-edge products to capture significant market share, underscoring the urgent requirement for enhanced diabetes care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Device Market Segments Analysis

Global Diabetes Device Market is segmented by Type, Distribution Channel, End Use and region. Based on Type, the market is segmented into BGM Devices. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Device Market

The global diabetes device market is significantly propelled by the escalating prevalence of diabetes around the world. This surge can be attributed to various factors, including sedentary lifestyles, poor dietary choices, obesity, and an aging demographic. As more individuals receive a diabetes diagnosis, the demand for devices that facilitate effective management and monitoring of the condition intensifies. This growing need underscores the importance of innovative diabetes management technologies, as patients seek solutions to help maintain their health and improve their quality of life in the face of widespread diabetes-related challenges.

Restraints in the Global Diabetes Device Market

The Global Diabetes Device market faces significant restraints related to the accuracy and reliability of its products, which are vital for successful diabetes management. Some devices may present discrepancies in measurements or experience calibration problems and technical malfunctions, all of which can affect the consistency of the data reported. These inaccuracies pose the risk of leading to misguided treatment decisions, ultimately jeopardizing patient safety. To foster confidence among healthcare providers and individuals managing diabetes, it is imperative to prioritize the enhancement of these devices' accuracy and reliability, ensuring they can be trusted to deliver precise readings consistently.

Market Trends of the Global Diabetes Device Market

The Global Diabetes Device market is experiencing a significant trend toward the evolution of insulin delivery systems, characterized by a surge in smart technologies. Insulin pumps and pens are increasingly equipped with advanced features and connectivity options, exemplified by their integration with Continuous Glucose Monitoring (CGM) systems for real-time glucose reading and automated insulin adjustments. This innovation enhances convenience and precision in insulin delivery, enabling personalized treatment plans that markedly improve glycaemic control for patients. As a result, the market is likely to witness accelerated growth as healthcare providers and patients increasingly embrace these cutting-edge solutions for diabetes management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Diabetes Device Market Size by Type & CAGR (2025-2032)

• Market Overview
• BGM Devices
  • Self-Monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
  • Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes
  • Jet Injectors

Global Diabetes Device Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Global Diabetes Device Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Homecare

Global Diabetes Device Market Size & CAGR (2025-2032)

• North America (Type, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Type, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DexCom (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Holdings (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY USA (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations